Glucagon-like peptide 1 receptor agonists and sodium glucose co-transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta-analysis

Citation
Mantsiou C, Karagiannis T, Kakotrichi P, et al. Diabetes Obes Metab 2020; epub ahead of press.